SBSB
ELV icon

Sullivan, Bruyette, Speros & Blaney’s Elevance Health ELV Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$267K Hold
745
– – 0.01% 256
2020
Q4 		$239K Buy
745
+12
+2% +$3.68K 0.01% 254
2020
Q3 		$197K Buy
733
+56
+8% +$15.1K 0.01% 251
2020
Q2 		$178K Hold
677
– – 0.01% 250
2020
Q1 		$154K Hold
677
– – 0.01% 240
2019
Q4 		$204K Sell
677
-11
-2% -$3.03K 0.01% 247
2019
Q3 		$165K Buy
+688
New +$189K 0.01% 266

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's ELV Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney held its Elevance Health (ELV) position steady in Q1 2021 at 745 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #256.

Sullivan, Bruyette, Speros & Blaney first reported a position in ELV in Q3 2019 and has held it in 7 quarters since. 1,212 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 745 shares of Elevance Health worth $267K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney left its Elevance Health share count unchanged in Q1 2021.
  • Elevance Health made up 0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #256 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Elevance Health in Q3 2019 and has held it in 7 quarters since.
  • 1,212 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.